These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 18774268

  • 1. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
    Malli E, Spiliopoulou I, Kolonitsiou F, Klapsa D, Giannitsioti E, Pantelidi K, Pratti A, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Frantzidou F, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou ED, Petinaki E.
    Int J Antimicrob Agents; 2008 Dec; 32(6):525-8. PubMed ID: 18774268
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS, Streit JM, Fritsche TR, Jones RN.
    Clin Microbiol Infect; 2006 Sep 18; 12(9):844-52. PubMed ID: 16882289
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
    Pfaller MA, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2007 Apr 18; 57(4):459-65. PubMed ID: 17240105
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
    Sader HS, Streit JM, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2004 Nov 18; 50(3):201-4. PubMed ID: 15541606
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Oct 18; 65(2):158-62. PubMed ID: 19748426
    [Abstract] [Full Text] [Related]

  • 8. [A study of in vitro activity of daptomycin against 2679 Gram-positive cocci].
    Zhang FF, Zhao CJ, Wang ZW, Liu WY, Yan W, Peng QS, Jiang S, Guo Y, Liu JB, Chen HB, Li HN, Wang Q, Wang H.
    Zhonghua Nei Ke Za Zhi; 2013 Jun 18; 52(6):474-9. PubMed ID: 24059993
    [Abstract] [Full Text] [Related]

  • 9. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).
    Castanheira M, Jones RN, Sader HS.
    Diagn Microbiol Infect Dis; 2008 Jun 18; 61(2):235-9. PubMed ID: 18314293
    [Abstract] [Full Text] [Related]

  • 10. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
    Johnson AP, Mushtaq S, Warner M, Livermore DM.
    Int J Antimicrob Agents; 2004 Oct 18; 24(4):315-9. PubMed ID: 15380254
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center.
    Smith PF, Booker BM, Ogundele AB, Kelchin P.
    Diagn Microbiol Infect Dis; 2005 Jul 18; 52(3):255-9. PubMed ID: 15935606
    [Abstract] [Full Text] [Related]

  • 14. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.
    Jorgensen JH, Crawford SA.
    J Clin Microbiol; 2006 Jun 18; 44(6):2126-9. PubMed ID: 16757608
    [Abstract] [Full Text] [Related]

  • 15. Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms.
    Streit JM, Jones RN, Sader HS.
    J Antimicrob Chemother; 2004 Apr 18; 53(4):669-74. PubMed ID: 14985278
    [Abstract] [Full Text] [Related]

  • 16. [In vitro activity of daptomycin and other antimicrobial agents against 499 strains of gram-positive cocci causing bloodstream infection].
    Yang QW, Wang H, Sun HL, Xu YC, Xie XL, Chen MJ.
    Zhonghua Nei Ke Za Zhi; 2009 Mar 18; 48(3):220-4. PubMed ID: 19576091
    [Abstract] [Full Text] [Related]

  • 17. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb 18; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Dec 18; 53(4):329-32. PubMed ID: 16263233
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
    Fritsche TR, Stilwell MG, Jones RN.
    Clin Microbiol Infect; 2005 Dec 18; 11(12):974-84. PubMed ID: 16307551
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
    Biedenbach DJ, Arhin FF, Moeck G, Lynch TF, Sahm DF.
    Int J Antimicrob Agents; 2015 Dec 18; 46(6):674-81. PubMed ID: 26541881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.